Brief: Sensorion Announces Australian Approval For PoC Trial Of Sens-401

Sensorion SA

01/07/2022 06:33

July 1 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION ANNOUNCES APPROVAL IN AUSTRALIA TO INITIATE
PROOF OF
CONCEPT CLINICAL TRIAL OF SENS-401 FOR RESIDUAL HEARING
PRESERVATION DURING COCHLEAR IMPLANTATION
    * AUSTRALIAN APPROVAL FOLLOWS RECENT TRIAL APPROVAL BY
REGULATORY
AUTHORITIES IN FRANCE

Source text for Eikon:  ID:nBwbWFHSba 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))